3Suppliers
3Customers
3Debt Items
8Related Chains

Serina Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
BOARD-OF-DIRECTORS BOARD-OF-DIRECTORS 90% On September 9, 2025, the Company entered into an unsecured convertible note (the “2025 Convertible Note”) with a member of the Company’s Board of Directors, providing for aggregate borrowing of up t…
INVESTORS INVESTORS 90% On March 19 and 20, 2026, the investors funded the full $ 15.0 million of the first closing, and the Company issued 0.4 million shares of common stock, 6.2 million Pre-Funded Warrants and 3.3 million…
JUVENESCENCE JUVENESCENCE 90% Juvenescence exercised Post-Merger Warrants to purchase 377,865 shares of the Company’s common stock at an exercise price of $ 13.20 per share, for a total purchase price of $ 5.0 million.

Serina Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
BOARD-OF-DIRECTORS BOARD-OF-DIRECTORS 85% On March 17, 2026, the Company entered into the March 2026 PIPE, a private placement of common stock and pre-funded warrants led by a member of the Board of Directors, at $2.25 per share.
INVESTORS INVESTORS 85% The Company entered into a Registration Rights Agreement with the investors pursuant to which the Company agreed to file a registration statement covering the resale of the registrable securities no …
JUVENESCENCE JUVENESCENCE 80% In connection with Agreement, the Company issued to Juvenescence warrants to purchase 755,728 shares of common stock at an exercise price of $ 18.00 per share (the “Replacement Incentive Warrants” an…

Serina Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SER-DEBT Debt stack $3.3M 90% Market cache reports total debt of $3.3M.
SER-DEBT-12470 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
SER-DEBT-12469 Warrants outstanding: 53980 90% xbrl warrant detail from xbrl 2025-12-31.

Serina Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Serina Therapeutics, Inc..

Serina Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
SER-OWNER-HIGHTOWER-ADVISORS-LLC HighTower Advisors, LLC 95% 13F/ownership overlay lists HighTower Advisors, LLC; shares held 11,980; ownership 0.11%; value $27,194; as of 2025-12-31.
SER-OWNER-VANGUARD-GROUP-INC Vanguard Group Inc 95% 13F/ownership overlay lists Vanguard Group Inc; shares held 180,013; ownership 1.67%; value $408,629; as of 2025-12-31.
SER-OWNER-BROADWOOD-CAPITAL-INC Broadwood Capital, Inc. 95% 13F/ownership overlay lists Broadwood Capital, Inc.; shares held 54,484; ownership 0.51%; value $123,678; as of 2025-12-31.
SER-OWNER-LINSCOMB-WEALTH-INC Linscomb Wealth, Inc. 95% 13F/ownership overlay lists Linscomb Wealth, Inc.; shares held 18,800; ownership 0.17%; value $42,675; as of 2025-12-31.
SER-OWNER-NORTHERN-TRUST-CORPORATION Northern Trust Corporation 95% 13F/ownership overlay lists Northern Trust Corporation; shares held 14,082; ownership 0.13%; value $31,966; as of 2025-12-31.
SER-OWNER-STATE-STREET-CORPORATION State Street Corporation 95% 13F/ownership overlay lists State Street Corporation; shares held 12,758; ownership 0.12%; value $28,960; as of 2025-12-31.
SER-OWNER-KEEL-POINT-LLC Keel Point, Llc 95% 13F/ownership overlay lists Keel Point, Llc; shares held 17,774; ownership 0.16%; value $40,346; as of 2025-12-31.
SER-OWNER-BLACKROCK-INC Blackrock Inc. 95% 13F/ownership overlay lists Blackrock Inc.; shares held 17,249; ownership 0.16%; value $39,155; as of 2025-12-31.
SER-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC Geode Capital Management, LLC 95% 13F/ownership overlay lists Geode Capital Management, LLC; shares held 30,409; ownership 0.28%; value $69,028; as of 2025-12-31.
SER-OWNER-WAVERLY-ADVISORS-LLC Waverly Advisors, LLC 95% 13F/ownership overlay lists Waverly Advisors, LLC; shares held 67,492; ownership 0.63%; value $153,206; as of 2025-12-31.
SER-OWNER-SIO-CAPITAL-MANAGEMENT-LLC Sio Capital Management, LLC 90% 13F overlay lists Sio Capital Management, LLC as top holder; 25 tracked holders.

Serina Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
NVO Novo Nordisk A/S 100.00 2
HOWL Werewolf Therapeutics, Inc. 100.00 2
JHG Janus Henderson Group plc 100.00 2
APAM Artisan Partners Asset Management Inc. 100.00 2
OPK OPKO Health, Inc. 100.00 2
SNYNF Sanofi 100.00 2
NKTR Nektar Therapeutics 100.00 2
ASND Ascendis Pharma A/S 36.29 1 ['spend']